Article info
Clinical and epidemiological research
Extended report
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
- Correspondence to Dr Sasha Bernatsky, Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Royal Victoria Hospital, 687 Pine Avenue West, V-Building, Room V2.09 Montreal, Quebec, Canada H3A 1A1; sasha.bernatsky{at}mail.mcgill.ca
Citation
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
Publication history
- Received May 28, 2012
- Revised November 5, 2012
- Accepted December 2, 2012
- First published January 8, 2013.
Online issue publication
December 04, 2013
Article Versions
- Previous version (8 January 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions